Dr. Karen Rowland Yeo, senior vice president, Client & Regulatory Strategy, Certara UK, describes how pioneering biosimulation is helping to predict drug exposures during pregnancy, providing opportunities for safer care and better outcomes.
Rebekah Jordan fired out some quick Q&As with the Verseon team to shed light on their PKI treatment for diabetic vision loss, its advantages over injection treatments as well as its effectiveness long term.
Cihan Likogullari, head of EMEA at Envirotainer, explores how calculating Total Landed Cost can help pharma companies make more informed decisions about packaging and the hidden costs that may come alongside it.
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
Rich Quelch, global head of marketing, Origin looks at the barriers to adoption of sustainable packaging alternatives in pharma and how the industry is working to overcome them.
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks.
Peter Jensen, CEO and Chairman, Normax delves into why it’s time for mRNA vaccine equality to be established across the globe, how mRNA vaccines can help drive down the cost of vaccines, and support the long-term battle against future pandemics.
Despite the carbon footprint from packaging pills to active pharmaceutical ingredient (API) development, Aleiya Lonsdale, head of Event, Lab Innovations, explains how pharma companies in the UK can do their part to help achieve net zero by 2040.
Pippa White, senior global account director for Life Sciences at SAS, explores the reservations many in the life sciences industry have and highlights why now is the time to embrace analytics in the cloud.
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics.
Portescap’s Jigar Fulia and Kanti Vala consider the selection criteria for biologics system motion solutions in delivery devices, and how this can help meet patient needs.
Here Ian Loudon, international sales and marketing manager at remote monitoring instrumentation manufacturer Omniflex, discusses how temperature monitoring systems can be cost effective, reliable and compliant with regulatory standards.
